We are live on ! Find out more
PAG

Private Advisor Group Portfolio holdings

AUM $21.8B
1-Year Est. Return 28.57%
This Fund
S&P 500
This Quarter Est. Return
-0.97%
1 Year Est. Return
+28.57%
3 Year Est. Return
+77.38%
5 Year Est. Return
+84.64%
10 Year Est. Return
+284.63%
AUM
$15.7B
AUM Growth
+$4.28B
Cap. Flow
+$4.58B
Cap. Flow %
29.11%
Top 10 Hldgs %
17.85%
Holding
2,135
New
154
Increased
1,492
Reduced
308
Closed
111
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DB icon
1901
Deutsche Bank
DB
$72.7B
$164K ﹤0.01%
12,880
+550
+4% +$6.9K
FNB icon
1902
FNB Corp
FNB
$6.5B
$164K ﹤0.01%
14,087
+682
+5% +$7.85K
AQN icon
1903
Algonquin Power & Utilities
AQN
$4.07B
$162K ﹤0.01%
+11,052
New +$170K
AMRS
1904
DELISTED
Amyris Inc.
AMRS
$161K ﹤0.01%
+11,700
New +$167K
EIM
1905
Eaton Vance Municipal Bond Fund
EIM
$464M
$160K ﹤0.01%
+11,971
New +$165K
TEVA icon
1906
Teva Pharmaceutical Industries Limited
TEVA
$45.8B
$159K ﹤0.01%
16,342
-21
-0.1% -$197
BBVA icon
1907
Banco Bilbao Vizcaya Argentaria
BBVA
$159B
$158K ﹤0.01%
24,010
+13,893
+137% +$89.7K
CFFN icon
1908
Capitol Federal Financial
CFFN
$1.09B
$158K ﹤0.01%
13,715
-7,934
-37% -$89.6K
APRN
1909
DELISTED
Blue Apron Holdings, Inc. Class A Common Stock
APRN
$158K ﹤0.01%
+1,783
New +$93.8K
HFRO
1910
Highland Opportunities and Income Fund
HFRO
$388M
$155K ﹤0.01%
14,392
+26
+0.2% +$278
FCEL icon
1911
FuelCell Energy
FCEL
$1.22B
$153K ﹤0.01%
+764
New +$152K
ACB
1912
Aurora Cannabis
ACB
$242M
$152K ﹤0.01%
2,203
+208
+10% +$14.8K
ADIL
1913
Adial Pharmaceuticals
ADIL
$14.7M
$152K ﹤0.01%
57
-2
-3% -$4.19K
PFO
1914
Flaherty & Crumrine Preferred and Income Opportunity Fund
PFO
$116M
$150K ﹤0.01%
11,685
+257
+2% +$3.38K
GCV
1915
Gabelli Convertible and Income Securities Fund
GCV
$90.9M
$147K ﹤0.01%
24,200
+4,500
+23% +$28.9K
TH icon
1916
Target Hospitality
TH
$1.84B
$146K ﹤0.01%
39,178
+19,901
+103% +$73.2K
RPAI
1917
DELISTED
RETAIL PROPERTIES OF AMERICA, INC.
RPAI
$144K ﹤0.01%
11,189
WIA
1918
Western Asset Inflation-Linked Income Fund
WIA
$182M
$143K ﹤0.01%
10,390
-1,280
-11% -$17.9K
JCO
1919
DELISTED
Nuveen Credit Opportunities 2022 Target Term Fund
JCO
$142K ﹤0.01%
17,375
-2,000
-10% -$16.6K
DFTX
1920
Definium Therapeutics
DFTX
$4.95B
$140K ﹤0.01%
4,034
+1,288
+47% +$55.7K
CLSD
1921
DELISTED
Clearside Biomedical
CLSD
$138K ﹤0.01%
1,533
-34
-2% -$3K
RES icon
1922
RPC Inc
RES
$1.37B
$138K ﹤0.01%
28,223
+11,745
+71% +$49.1K
CLNE icon
1923
Clean Energy Fuels
CLNE
$381M
$136K ﹤0.01%
16,744
-586
-3% -$4.66K
IGR
1924
CBRE Global Real Estate Income Fund
IGR
$625M
$136K ﹤0.01%
5,435
-333
-6% -$8.97K
RIG icon
1925
Transocean
RIG
$6.63B
$136K ﹤0.01%
35,817
-5,150
-13% -$18.7K

Similar funds

Private Advisor Group's Q3 2021 Portfolio in Review

As of Q3 2021, Private Advisor Group held 2,135 positions worth $15.7B, up 37% from $11.4B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Private Advisor Group deployed $4.58B of net new capital in Q3 2021, opening 154 new positions and adding to 1,492 existing holdings. Its largest new stake was Dimensional World ex US Core Equity 2 ETF: 1,063,663 shares worth $27.5M.

By sector, the portfolio is most concentrated in Miscellaneous at 61% of assets, down from 65% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was iShares S&P Small-Cap 600 Growth ETF, an estimated $9.52M trimmed.

  • Private Advisor Group's largest Q3 2021 buy was Dimensional World ex US Core Equity 2 ETF: 1,063,663 shares worth $27.5M.
  • Private Advisor Group added most to Apple in Q3 2021, an estimated $174M increase.
  • Private Advisor Group's biggest Q3 2021 reduction was iShares S&P Small-Cap 600 Growth ETF, cutting an estimated $9.52M.
  • Private Advisor Group fully exited Invesco Dorsey Wright Energy Momentum ETF in Q3 2021, selling an estimated $5.01M.
  • Private Advisor Group's ten largest holdings make up 18% of its $15.7B portfolio in Q3 2021.
  • Private Advisor Group opened 154 new positions and closed 111 in Q3 2021.
  • Private Advisor Group's portfolio value rose 37% quarter-over-quarter to $15.7B.

Based on Private Advisor Group's 13F filing for Q3 2021, filed 14 Oct 2021.